AmSurg shares receive 'buy' rating: 5 notes

Analysts gave AmSurg shares a "buy" rating, according to Community Financial News.

Here are five notes:

1. Analysts have an average 12-month target price of $92.38 on AmSurg shares.  

2. On August 26, the shares increased 0.36 percent, reaching $77.38.  

3. The company has a 52-week low of $54.11 and a 52-week high of $87.42.

4. The 50-day moving average is $74.13 and the 200-day moving average is $74.41.

5. The market cap is $4.16 billion.

More articles on surgery centers:
10 largest ASC chains in the US
$10M medical campus opens with 8.5k-sq-ft ASC: 4 key notes
$8.9M Fort Meade Surgical Center opens: 3 key notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months